Tricia Rutherford

Liverpool, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Metabolic targeting of pantothenate by medium chain fats in glioblastoma cells.

Metabolic targeting of pantothenate by medium chain fats in glioblastoma cells.

Journal: BMC cancer
Published: November 17, 2025

Energy metabolism, adenosine, and glutamate signaling reprogramming by decanoic acid in Glut1 disorder syndrome.

Energy metabolism, adenosine, and glutamate signaling reprogramming by decanoic acid in Glut1 disorder syndrome.

Journal: Epilepsia open
Published: July 28, 2025

SH-SY5Y cells undergo changes in peroxisomal metabolism when exposed to decanoic acid.

SH-SY5Y cells undergo changes in peroxisomal metabolism when exposed to decanoic acid.

Journal: Journal of neurochemistry
Published: May 02, 2024

Protective effects of medium chain triglyceride diet in a mouse model of Dravet syndrome.

Protective effects of medium chain triglyceride diet in a mouse model of Dravet syndrome.

Journal: Epilepsia
Published: March 25, 2021

K.Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy.

K.Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy.

Journal: Brain communications
Published: March 03, 2021

A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model.

A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model.

Journal: Oncotarget
Published: June 13, 2017

Neuronal decanoic acid oxidation is markedly lower than that of octanoic acid: A mechanistic insight into the medium-chain triglyceride ketogenic diet.

Neuronal decanoic acid oxidation is markedly lower than that of octanoic acid: A mechanistic insight into the medium-chain triglyceride ketogenic diet.

Journal: Epilepsia
Published: June 02, 2017

The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome.

The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome.

Journal: Oncotarget
Published: March 10, 2017

The pleiotropic effects of decanoic acid treatment on mitochondrial function in fibroblasts from patients with complex I deficient Leigh syndrome.

The pleiotropic effects of decanoic acid treatment on mitochondrial function in fibroblasts from patients with complex I deficient Leigh syndrome.

Journal: Journal of inherited metabolic disease
Published: October 30, 2015

Mitochondria: The ketogenic diet--A metabolism-based therapy.

Mitochondria: The ketogenic diet--A metabolism-based therapy.

Journal: The international journal of biochemistry & cell biology
Published: November 07, 2014

The ketogenic diet component decanoic acid increases mitochondrial citrate synthase and complex I activity in neuronal cells.

The ketogenic diet component decanoic acid increases mitochondrial citrate synthase and complex I activity in neuronal cells.

Journal: Journal of neurochemistry
Published: November 06, 2013
Showing 1-11 of 11

Last Updated: 09/26/2026